In a randomized, double-blind, placebo-controlled study, administering 100 mg of CBD twice daily for 13 weeks positively impacted insulin resistance and glucose-dependent insulinotropic peptide in non-insulin-treated type 2 diabetes patients. This evidence concerns the gene INS and type 2 diabetes mellitus.